Apex Medical Corp.

TWSE:4106.TW

22 (TWD) • At close September 1, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) TWD.

2024202320222021202020192018201720162015201420132012201120102009
Operating Activities:
Net Income 147.844209.853200.537138.081124.844128.426150.271151.766162.13224.632251.973203.557205.106233.898179.441209.083
Depreciation & Amortization 95.21193.76393.31193.54679.27480.84561.94675.81190.194102.297109.526104.87762.01744.45850.16157.914
Deferred Income Tax 0000000000000000
Stock Based Compensation 0000000000000000
Change In Working Capital 11.576179.613-197.957-177.815114.5767.956-64.804-15.456-4.5784.394-65.746-21.062-10.787-10.694-5.27752.841
Accounts Receivables 105.36219.907-143.403-66.84338.3571.553-60.191-37.649-47.87440.217-15.927-19.75224.564000
Inventory 4.491132.2172.388-180.58957.3514.5-13.623-31.4141.876-45.208-20.339-11.43317.221-0.09-48.59951.286
Accounts Payables -44.6684.445-31.1385.041-10.128-70.58826.908-34.38475.328-17.038000000
Other Working Capital -53.60623.044-25.812-15.42429.004-7.509-51.18115.958-6.45449.602-45.407-9.629-28.008-10.60443.3221.555
Other Non Cash Items -41.397-27.571-13.746-34.807-39.373-43.603-28.423-33.909-29.16-54.313-47.424-68.318-1.97718.225-33.015-14.552
Operating Cash Flow 213.234455.65882.14519.005279.321173.624118.99178.212218.586277.01248.329219.054254.359285.887191.31305.286
Investing Activities:
Investments In Property Plant And Equipment -56.909-28.826-47.992-52.292-47.112-32.354-172.56-24.431-44.389-37.273-61.665-62.318-64.418-18.473-17.098-14.048
Acquisitions Net 0-3.1980.577-3.01-98.596-0.3451.602-32.987-266.2461.3915.526-0.2770000
Purchases Of Investments -5.4-20.765-0.577-2.445-120-114-569.861-30.065-3.724-190.514-219.428-207.9980.53371.895-10.83735.347
Sales Maturities Of Investments 0015.42535.192330.573246.943224.528-0.12559.985219.428207.998158.4420000
Other Investing Activites 0.782-0.106-0.3346.63278.578-64.73-1.6181.5875.3611.0323.6690.07455.521-13.9914.92126.082
Investing Cash Flow -61.527-52.895-32.901-15.923143.44335.514-517.909-86.021-249.013-5.936-63.9-112.077-8.36439.432-13.01447.381
Financing Activities:
Debt Repayment -51.879-96.776-72.307152.765-220.377-266.783122.054-45.16117.6530-81.50521.14585.21383.362-55.044-220.107
Common Stock Issued 000000387.325000000000
Common Stock Repurchased 0000000000000000
Dividends Paid -80.729-85.775-55.501-55.501-45.41-65.592-66.708-66.708-83.385-83.385-58.369-41.693-145.925-83.386-122.732-81.48
Other Financing Activities -20.378-17.83-18.025-15.388-13.945113.5970.0912.2812.305-53.692-12.508-80.80221.0590-0.426-2.055
Financing Cash Flow -152.986-200.381-145.83381.876-279.732-218.778442.762-109.58736.573-137.077-152.45-101.35-39.653-0.024-178.202-303.642
Other Information:
Effect Of Forex Changes On Cash 19.340.71748.642-61.888-92.326-18.119-6.147-8.879-49.636-9.276-1.47614.559-7.7763.439-5.386-2.996
Net Change In Cash 18.061203.099-47.94723.0750.706-27.75937.696-26.275-43.49124.72130.50320.186-55.297151.268-5.29246.029
Cash At End Of Period 666.44648.379445.28493.227470.157419.451447.21409.514435.789479.279354.558324.055462.311517.608366.34371.632